We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+14.73%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.51B
AUM Growth
-$25.3M
Cap. Flow
-$166M
Cap. Flow %
-11.02%
Top 10 Hldgs %
21.48%
Holding
1,502
New
400
Increased
305
Reduced
321
Closed
403

Top Buys

Rank Stock Value
1
VIPS icon
Vipshop
VIPS
+$11.8M
2
EDU icon
New Oriental
EDU
+$11.7M
3
LI icon
Li Auto
LI
+$10.4M
4
HES
Hess
HES
+$9.96M
5
ACMR icon
ACM Research
ACMR
+$7.73M

Sector Composition

Rank Sector Weight
1 Technology 14.24%
2 Consumer Discretionary 12.06%
3 Healthcare 10.13%
4 Industrials 10.12%
5 Energy 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFOR
926
Everforth Inc
EFOR
$1.33B
$208K 0.01%
+2,164
New +$189K
MHO icon
927
M/I Homes
MHO
$3.74B
$207K 0.01%
1,500
-3,740
-71% -$374K
CAH icon
928
Cardinal Health
CAH
$55.5B
$206K 0.01%
2,044
-3,794
-65% -$376K
AOSL icon
929
Alpha and Omega Semiconductor
AOSL
$1.03B
$206K 0.01%
+7,900
New +$195K
NUS icon
930
Nu Skin
NUS
$250M
$206K 0.01%
+10,600
New +$196K
BRKR icon
931
Bruker
BRKR
$8.58B
$206K 0.01%
+2,801
New +$179K
SHW icon
932
Sherwin-Williams
SHW
$88.1B
$205K 0.01%
+658
New +$177K
ASTE icon
933
Astec Industries
ASTE
$991M
$205K 0.01%
5,505
-751
-12% -$27.7K
CNC icon
934
Centene
CNC
$32.9B
$205K 0.01%
2,759
-23,292
-89% -$1.68M
DAKT icon
935
Daktronics
DAKT
$1.03B
$205K 0.01%
24,127
+4,340
+22% +$41.4K
ROIV icon
936
Roivant Sciences
ROIV
$25.8B
$204K 0.01%
18,201
-4,079
-18% -$39.8K
GTLS
937
DELISTED
Chart Industries
GTLS
$204K 0.01%
+1,499
New +$203K
AM icon
938
Antero Midstream
AM
$10.4B
$203K 0.01%
+16,230
New +$205K
IIIV icon
939
i3 Verticals
IIIV
$328M
$203K 0.01%
+9,591
New +$192K
QCOM icon
940
CALL
Qualcomm
QCOM
$170B
$202K 0.01%
+1,400
New +$173K
QCOM icon
941
PUT
Qualcomm
QCOM
$170B
$202K 0.01%
+1,400
New +$173K
MSTR icon
942
Strategy Inc
MSTR
$37.4B
$202K 0.01%
+3,200
New +$152K
SAIC icon
943
Saic
SAIC
$5.3B
$201K 0.01%
1,613
-1,207
-43% -$140K
CPNG icon
944
Coupang
CPNG
$29.1B
$199K 0.01%
+12,300
New +$203K
PACB icon
945
Pacific Biosciences
PACB
$357M
$198K 0.01%
+20,159
New +$165K
UTI icon
946
Universal Technical Institute
UTI
$1.47B
$195K 0.01%
+15,575
New +$158K
CLAR icon
947
Clarus
CLAR
$145M
$195K 0.01%
28,268
+15,586
+123% +$91.5K
PWP icon
948
Perella Weinberg Partners
PWP
$1.26B
$195K 0.01%
+15,932
New +$174K
RXRX icon
949
Recursion Pharmaceuticals
RXRX
$1.76B
$195K 0.01%
19,733
-23,226
-54% -$166K
MAT icon
950
Mattel
MAT
$4.21B
$193K 0.01%
10,245
-9,594
-48% -$187K

Similar funds

Prelude Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Prelude Capital Management held 1,502 positions worth $1.51B, down 1.6% from $1.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Prelude Capital Management withdrew a net $166M in Q4 2023, closing 403 positions and reducing 321 holdings. Its most notable exit was Activision Blizzard, an estimated $20.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in New Oriental worth $12.4M.

  • Prelude Capital Management's largest Q4 2023 buy was New Oriental: 168,713 shares worth $12.4M.
  • Prelude Capital Management added most to Vipshop in Q4 2023, an estimated $11.8M increase.
  • Prelude Capital Management's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $7.3M.
  • Prelude Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $20.8M.
  • Prelude Capital Management's ten largest holdings make up 21% of its $1.51B portfolio in Q4 2023.
  • Prelude Capital Management opened 400 new positions and closed 403 in Q4 2023.
  • Prelude Capital Management's portfolio value fell 1.6% quarter-over-quarter to $1.51B.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.